Clinical Innovation
from Monaco
Since 2001, R&D Pharma has worked on battling age related conditions.
Products
Explore our current
and pipeline products
With more than two decades of experience, R&D Pharma combines the agility of a family-scale organization with the discipline of pharmaceutical operations. Its strategy is focused on identifying targeted medical needs, building compliant and scalable solutions, and cultivating long-term partnerships within the healthcare ecosystem. R&D Pharma stands at the intersection of regulatory expertise, operational excellence, and dermatological innovation, committed to scientific rigor, quality oversight, and sustainable growth.
Our multiple regulatory profile
R&D Pharma operates across multiple regulatory frameworks:
Pharmaceutical Activity
- Marketing Authorization Holder (MAH)
- Exploit ant in accordance with applicable national regulations
- Responsible for batch certification and release
- Manufacturing outsourced to qualified GMP-compliant partners
Medical Device Activity
- ISO certified manufacturing site
- Distributor within the European market
- Sponsor of clinical investigations for investigational devices
Our approach
Our current focus
- Development of investigational dermatology technologies for aged related skin disorders
- Clinical evaluation of medical device-based approaches
- Scientific collaboration with healthcare professionals
Our development philosophy is built on:
- Scientific rigor
- Regulatory compliance
- Ethical clinical research
- Long-term innovation
Some technologies described on this website are currently under regulatory review or clinical investigation and are not CE marked.
We collaborate with qualified investigators, clinical research organizations, and regulatory experts to ensure that all development activities meet applicable standards.